Award
NIH Reporter #4R00CA296940-02
Adverse gut microbiome promotes resistance immune checkpoint inhibitors via chronic inflammation
Recipient
Not specified
Award Amount
$248,658.00
Ceiling
$248,658.00
Awarded
April 17, 2026
Identifier
4R00CA296940-02
Research project awarded by the National Cancer Institute investigating the role of adverse gut microbiome in resistance to immune checkpoint inhibitors through chronic inflammation.
Description
This is a research project funded by the NIH/NCI focusing on microbiome and cancer immunotherapy.